N02CD02 galcanezumab
ATC group of level 5 – chemical substance · in plain English: medicines for migraine
This site has the patient leaflet or the SPC of 3 medicines in this group.
- 3 prescription only (POM)
Active substance: Galcanezumab – all medicines with this substance, also in combinations.
Place in the ATC classification
How to read ATC codes – what the levels mean and what a code does not tell you.
- N Nervous system drugs 4,502 medicines
- N02 Analgesics 1,042 medicines
- N02C Antimigraine preparations 110 medicines
- N02CD Calcitonin gene-related peptide (CGRP) antagonists 10 medicines
- N02CD02 galcanezumab 3 medicines
- N02CD Calcitonin gene-related peptide (CGRP) antagonists 10 medicines
- N02C Antimigraine preparations 110 medicines
- N02 Analgesics 1,042 medicines
Medicines
| Medicine | Legal category |
|---|---|
| E Mgality 120 mg - solution for injection Pre-filled pen SPC | Prescription only (POM) |
| Emgality 120 mg solution for injection in Pre-filled pen | Prescription only (POM) |
| Emgality 120 mg solution for injection Pre-filled pen | Prescription only (POM) |
Other groups of the same level
- N02CD01 erenumab 4 medicines
- N02CD03 fremanezumab 2 medicines
Other names of the ATC group
- Italian: N02CD02 Galcanezumab
- Turkish: N02CD02 galcanezumab
- German (Switzerland): N02CD02 Galcanezumab
- French (Switzerland): N02CD02 Galcanezumab
- Italian (Switzerland): N02CD02 Galcanezumab
- English (Canada): N02CD02 Galcanezumab
- French (Canada): N02CD02 Galcanezumab
- Czech: N02CD02 Galkanezumab
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group N02CD02
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.
